Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease vascular disease
Phenotype |diabetes
Sentences 529
PubMedID- 23294625 Several potential new biomarkers for cardiovascular diseases in diabetes have appeared during recent years.
PubMedID- 21963020 Preliminary evidence in support of fruit intake for the prevention of cardiovascular disease in patients with type 2 diabetes mellitus (t2dm) is still limited.
PubMedID- 26485682 Sympathetic abnormalities play an important role in the pathophysiology of cardiovascular disease associated with metabolic syndrome, diabetes mellitus and obesity [1–4].
PubMedID- 20647285 Objective: to determine the extent to which intensive dietary intervention can influence glycaemic control and risk factors for cardiovascular disease in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment.
PubMedID- 23940992 Study included 313 normoalbuminuric patients with type 1 diabetes, none showed signs of adrenal, renal, or cardiovascular diseases.
PubMedID- 24344928 Logistic regression was used to estimate the odds ratios of prevalent cardiovascular disease associated with self-reported diabetes, and with measured random blood glucose levels among participants with no history of diabetes, adjusting simultaneously for age, sex, area, education, smoking, alcohol, blood pressure and physical activity.
PubMedID- 21911774 The need to manage the risks for cardiovascular disease associated with type 1 diabetes should be considered from childhood.
PubMedID- 22952467 (b) that insulin resistance is the major determinant of vascular disease in patients with diabetes deserves reconsideration.
PubMedID- 23071607 Background: peripheral vascular disease in pre-diabetes may involve altered sympathetically-mediated vascular control.
PubMedID- 24023876 Activity causing sweating and/or breathlessness), current daily smoking (cigarettes/cigar/pipe), self-reported diabetes and history of cardiovascular disease [cvd] (angina pectoris, myocardial infarction or stroke) were obtained from the questionnaires.
PubMedID- 26055067 This paper describes the relationship of baseline fgf21 levels and new on-study microvascular disease in patients with type 2 diabetes from the field study.
PubMedID- 26063568 Diagnoses of malignancy, diabetes with complications, cerebrovascular disease, as well as acute and chronic renal failure were used to assess additional comorbidity.
PubMedID- 24889279 Smoking, diabetes, metabolic syndrome, history of cardiovascular disease, increased waist circumference, and elevated pre-treatment ldl-c level were all associated with not reaching ldl-c goals.
PubMedID- 21390057 Pulse pressure and systolic night-day ratio interact in prediction of macrovascular disease in patients with type 2 diabetes mellitus.
PubMedID- 20860758 Although data suggest that the control of hyperglycaemia may have a different impact on primary and secondary prevention of cardiovascular disease in patients with type 2 diabetes, in the navigator study, patients in these two groups were pooled and evaluated together (38).
PubMedID- 21035578 There is also strong evidence that blood pressure targets for populations at high risk of cardiovascular disease, including those with diabetes, coronary artery disease, and chronic kidney disease, should be lower than 140/90 mm hg.
PubMedID- 21291555 Apart from the combination of cardiovascular disease with comorbid diabetes reported by 60.2%, arthritis was consistently among the most commonly reported comorbid condition, being reported by a third of people with the index conditions.
PubMedID- 22526620 Poorly managed type 1 diabetes can lead to cardiovascular disease, diabetic neuropathy, and diabetic retinopathy.
PubMedID- 22210236 Objective: depression in type 2 diabetes is associated with obesity, cardiovascular disease, and mortality.
PubMedID- 24728837 The presence of cardiovascular diseases was significantly associated with diabetes mellitus in patients with copd.
PubMedID- 20191077 Proactive trial36 enrolled 5238 patients with type 2 diabetes who had evidence of macrovascular disease in a prospective, randomized study.
PubMedID- 23144257 Hypertension and diabetes are initial stages of cardiovascular disease, and the risk is elevated because of the high prevalence of tobacco smoking among men.
PubMedID- 25995772 In addition, oxldl is an important factor for predicting cardiovascular disease in patients with diabetes [19].
PubMedID- 24227183 Level of physical activity associated with risk of cardiovascular diseases and mortality in patients with type-2 diabetes: report from the swedish national diabetes register.
PubMedID- 23008738 However, the results varied by population (healthy adults, adults at cardiovascular disease risk, adults with type 2 diabetes, etc.)
PubMedID- 23540820 Screening for peripheral vascular disease in patients with type 2 diabetes in malta in a primary care setting.
PubMedID- 26516107 The aim of this study was to analyse all-cause mortality and cardiovascular disease (cvd) outcomes in patients with type 2 diabetes detected by screening or diagnosed clinically.
PubMedID- 26413719 Model 2 represents model 1 plus adjustment for body mass index and comorbidities including hypertension, diabetes mellitus and history of cerebrovascular disease.
PubMedID- 22111042 In addition, hypertension, dyslipidemia and associated diseases, various macrovascular diseases associated with diabetes, and a history of complications from vascular disease were verified through surveys.
PubMedID- 25391871 Objective: to explore the change and possible role of blood lipids during the course of plaque formation induced by diabetes mellitus in patients with ischemic cerebral vascular disease.
PubMedID- 25903071 Evidence for an excess risk of cardiovascular disease associated with diabetes in women is increasing, an observation that urges intensified treatment and management of female diabetes patients.
PubMedID- 22301120 The outcome of cardiovascular diseases in patients with diabetes is known to be better in the japanese population.
PubMedID- 20653327 Therapeutic potential of aleglitazar, a new dual ppar-alpha/gamma agonist: implications for cardiovascular disease in patients with diabetes mellitus.
PubMedID- 24705616 We further investigated the association between diabetes and different phenotypes of vascular disease in women and men (table 2).
PubMedID- 24498934 Ev-markers and the risk of new onset type 2 diabetes in patients with manifest cardiovascular disease.
PubMedID- 23978254 From february 2002 to january 2005, we enrolled 135 consecutive asymptomatic patients (74 male; mean age, 63 ± 9 years) with type 2 diabetes without a history of cardiovascular disease.
PubMedID- 21569580 Previous reports have outlined the prognostic importance of undiagnosed diabetes in patients with different cardiovascular diseases [16,20-22].
PubMedID- 20929996 Therefore, the aim of our study was to evaluate whether repeated episodes of hypoglycemia represent an aggravating factor for macrovascular disease in subjects with type 1 diabetes through early atherosclerosis-vascular assessment.
PubMedID- 25848912 The association between circulating mmps and macrovascular disease in patients with type 1 diabetes has not been investigated, while studies on the associations between mmp levels and microvascular complications seem contradictory.
PubMedID- 22375126 Participants were excluded if they failed a screening cardiac stress test, had type 1 diabetes, had a history of major cardiovascular disease, had orthopedic or rheumatologic problems that impeded exercise, and/or started or changed cholesterol drug use within the previous 3 months.
PubMedID- 26246173 Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the american heart association and the american diabetes association.
PubMedID- 19754853 Methods: cardiovascular disease patients with diabetes mellitus (group a, n = 14) and nondiabetic patients with cvd only (group b, n = 10) took atorvastatin 80 mg per day for a period of 8-10 weeks.
PubMedID- 22936794 At the time of diagnosis of diabetes, patients with established cardiovascular disease had significantly lower mean levels of blood pressure than those without cardiovascular disease (table 1).
PubMedID- 26089876 Two adjacent regions upstream cdkn2b on chromosome 9p21 have been associated with type 2 diabetes (t2d) and progression of cardiovascular disease (cvd).
PubMedID- 23878823 Atherosclerosis that is often found in type 2 diabetes is a complication of macrovascular disease that increases the risk for myocardial infarction and strokes.
PubMedID- 23625211 In part ii of this review, we describe the epidemiology and clinical consequences of vascular disease in patients with diabetes, and discuss the efficacy of risk factor modification and antiplatelet treatment.
PubMedID- 21470634 Background: accelerated cardiovascular disease in patients with type i diabetes (tid) is a well-described condition and serious clinical obstacle.
PubMedID- 23385371 While some authorities, primarily those funded by the food industry, have argued that the high amounts of added sugars in food and beverages may contribute to health risks solely as a consequence of their caloric content, there is also mounting evidence that fructose may have a specific ability to cause fatty liver (which can progress to cirrhosis of the liver), high triglycerides in blood (which can contribute to cardiovascular disease), insulin resistance (leading to type 2 diabetes) and increased appetite (which obviously can lead to obesity) [5,6].
PubMedID- 22021772 The excess risk of vascular disease in persons with diabetes is about twofold compared with those without diabetes and is independent of other conventional cardiovascular risk factors.
PubMedID- 23245213 Background: abnormal circadian blood pressure patterns have been associated with cardiovascular disease in diabetes mellitus.

Page: 1 2 3 4 5 6 7 8 9 10 11